MedPath

Informed decision-making with and for people with dementia – evaluation of an education program for legal representatives

Not Applicable
Completed
Conditions
Proxy decision-making for people with dementia
Mental and Behavioural Disorders
Unspecified dementia
Registration Number
ISRCTN17960111
Lead Sponsor
Deutsche Forschungsgemeinschaft
Brief Summary

2017 Protocol article in https://pubmed.ncbi.nlm.nih.gov/28915861/ protocol (added 06/01/2021) 2024 Results article in https://doi.org/10.3390/geriatrics9030060 (added 19/07/2024)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
216
Inclusion Criteria

1. Legal representatives in Germany, both professional and volunteer
2. Represent at least one person with dementia (assessed by the legal representative and/or medical diagnosis)

Exclusion Criteria

Participation in the PRODECIDE education program (either the whole program or a single module)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Knowledge (understanding of decision-making processes in healthcare affairs and realistic expectations regarding probabilities of benefits and harms of percutaneous endoscopic gastrostomy, physical restraints and antipsychotics to people with dementia), assessed using a novel questionnaire at T1 (up to 2 weeks after intervention)
Secondary Outcome Measures
NameTimeMethod
1. Sufficient knowledge, measured with the same knowledge test as the primary outcome using a cut-off of 70% correct answers, at T1 (up to 2 weeks after intervention)<br>2. Sustainable knowledge, assessed with the same knowledge test at T3 (6-month follow-up) <br>3. The use of percutaneous endoscopic gastrostomies, physical restraints and antipsychotics, using data extracted from routine documentation and standardized documentation sheets at baseline and T3 (6-month follow-up) <br>4. Result of the first decision after intervention regarding percutaneous endoscopic gastrostomy, physical restraints and antipsychotics, assessed using documentation sheets and telephone interviews at T2 (3-month follow-up) and T3 (6-month follow-up)
© Copyright 2025. All Rights Reserved by MedPath